214 related articles for article (PubMed ID: 32140187)
1. Label-free quantitative identification of abnormally ubiquitinated proteins as useful biomarkers for human lung squamous cell carcinomas.
Lu M; Chen W; Zhuang W; Zhan X
EPMA J; 2020 Mar; 11(1):73-94. PubMed ID: 32140187
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitinomics revealed disease- and stage-specific patterns relevant for the 3PM approach in human sigmoid colon cancers.
Yang H; Li N; Chen L; Zhou L; Zhou Y; Liu J; Jia W; Chen R; Su J; Yang L; Gong X; Zhan X
EPMA J; 2023 Sep; 14(3):503-525. PubMed ID: 37605648
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitination-mediated molecular pathway alterations in human lung squamous cell carcinomas identified by quantitative ubiquitinomics.
Zhan X; Lu M; Yang L; Yang J; Zhan X; Zheng S; Guo Y; Li B; Wen S; Li J; Li N
Front Endocrinol (Lausanne); 2022; 13():970843. PubMed ID: 36187110
[TBL] [Abstract][Full Text] [Related]
4. Clinically relevant stratification of lung squamous carcinoma patients based on ubiquitinated proteasome genes for 3P medical approach.
Yang J; Ouedraogo SY; Wang J; Li Z; Feng X; Ye Z; Zheng S; Li N; Zhan X
EPMA J; 2024 Mar; 15(1):67-97. PubMed ID: 38463626
[TBL] [Abstract][Full Text] [Related]
5. Quantitative phosphoproteomics reveals molecular pathway network alterations in human early-stage primary hepatic carcinomas: potential for 3P medical approach.
Zhang Y; Li N; Yang L; Jia W; Li Z; Shao Q; Zhan X
EPMA J; 2023 Sep; 14(3):477-502. PubMed ID: 37605650
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
[TBL] [Abstract][Full Text] [Related]
7. Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine.
Bilguun EO; Kaira K; Kawabata-Iwakawa R; Rokudai S; Shimizu K; Yokobori T; Oyama T; Shirabe K; Nishiyama M
BMC Cancer; 2020 Sep; 20(1):935. PubMed ID: 32993587
[TBL] [Abstract][Full Text] [Related]
8. Integrative Analysis Reveals STC2 as a Prognostic Biomarker of Laryngeal Squamous Cell Carcinoma.
Zhong R; Zhan J; Zhang S
Appl Biochem Biotechnol; 2023 Oct; ():. PubMed ID: 37792175
[TBL] [Abstract][Full Text] [Related]
9. KAI1/CD82 and MRP1/CD9 serve as markers of infiltration, metastasis, and prognosis in laryngeal squamous cell carcinomas.
Zhang BH; Liu W; Li L; Lu JG; Sun YN; Jin DJ; Xu XY
Asian Pac J Cancer Prev; 2013; 14(6):3521-6. PubMed ID: 23886139
[TBL] [Abstract][Full Text] [Related]
10. Expression of vimentin (VIM) and metastasis-associated 1 (MTA1) protein in laryngeal squamous cell carcinoma are associated with prognostic outcome of patients.
Karamagkiolas S; Giotakis I; Kyrodimos E; Giotakis EI; Kataki A; Karagianni F; Lazaris AM
Am J Otolaryngol; 2019; 40(4):487-493. PubMed ID: 30979652
[TBL] [Abstract][Full Text] [Related]
11. A novel signature derived from metabolism-related genes GPT and SMS to predict prognosis of laryngeal squamous cell carcinoma.
Shen Y; Huang Q; Zhang Y; Hsueh CY; Zhou L
Cancer Cell Int; 2022 Jul; 22(1):226. PubMed ID: 35804447
[TBL] [Abstract][Full Text] [Related]
12. Cyr61/CCN1 overexpression induces epithelial-mesenchymal transition leading to laryngeal tumor invasion and metastasis and poor prognosis.
Liu Y; Zhou YD; Xiao YL; Li MH; Wang Y; Kan X; Li QY; Lu JG; Jin DJ
Asian Pac J Cancer Prev; 2015; 16(7):2659-64. PubMed ID: 25854342
[TBL] [Abstract][Full Text] [Related]
13. Identification of core biomarkers associated with pathogenesis and prognostic outcomes of laryngeal squamous-cell cancer using bioinformatics analysis.
Chen W; Liao L; Lai H; Yi X; Wang D
Eur Arch Otorhinolaryngol; 2020 May; 277(5):1397-1408. PubMed ID: 32067095
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA MTCL1 promotes advanced laryngeal squamous cell carcinoma progression by inhibiting C1QBP ubiquitin degradation and mediating beta-catenin activation.
Wang Z; Sun A; Yan A; Yao J; Huang H; Gao Z; Han T; Gu J; Li N; Wu H; Li K
Mol Cancer; 2022 Apr; 21(1):92. PubMed ID: 35366893
[TBL] [Abstract][Full Text] [Related]
15. SPINK5 is a Prognostic Biomarker Associated With the Progression and Prognosis of Laryngeal Squamous Cell Carcinoma Identified by Weighted Gene Co-Expression Network Analysis.
Liu J; Zhao J; Xu J; Sun Q; Qin X; Chen G; Gao T; Bai G; Guo Z
Evol Bioinform Online; 2022; 18():11769343221077118. PubMed ID: 35140453
[TBL] [Abstract][Full Text] [Related]
16. Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis.
Ji F; Zhou M; Sun Z; Jiang Z; Zhu H; Xie Z; Ouyang X; Zhang L; Li L
Cancer Commun (Lond); 2021 Oct; 41(10):1007-1023. PubMed ID: 34196494
[TBL] [Abstract][Full Text] [Related]
17. Identification of gene expression models for laryngeal squamous cell carcinoma using co-expression network analysis.
Yang CW; Wang SF; Yang XL; Wang L; Niu L; Liu JX
Medicine (Baltimore); 2018 Feb; 97(7):e9738. PubMed ID: 29443735
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of proteasome reveals basal mitochondrial ubiquitination.
Sulkshane P; Duek I; Ram J; Thakur A; Reis N; Ziv T; Glickman MH
J Proteomics; 2020 Oct; 229():103949. PubMed ID: 32882436
[TBL] [Abstract][Full Text] [Related]
19. Identifying prognostic lncRNAs based on a ceRNA regulatory network in laryngeal squamous cell carcinoma.
Shi Y; Yang D; Qin Y
BMC Cancer; 2021 Jun; 21(1):705. PubMed ID: 34130645
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis reveals COPB2 and RYK associated with tumor stages of larynx squamous cell carcinoma.
Zhou G; Zhang S; Jin M; Hu S
BMC Cancer; 2022 Jun; 22(1):667. PubMed ID: 35715770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
